Alan Md Weiss
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan Md Weiss has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Winslow
Department of Medicine, Endeavor Health, Evanston, IL
2 shared publications - Dana P. Edelson
Department of Medicine, University of Chicago, Chicago, IL, United States
2 shared publications - Deveendra Amin
BayCare, Clearwater, FL
2 shared publications - Emily Gilbert
Department of Medicine, Loyola University Medical Center, Chicago, IL
2 shared publications - Kyle A. Carey
Department of Medicine, University of Chicago, Chicago, IL, United States
2 shared publications - Matthew Michael Churpek
Department of Medicine, University of Wisconsin-Madison, Madison, WI
2 shared publications
Latest Publications
- Open Access
- 26 March 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (4) , e1232
Multicenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score
BACKGROUND: Early detection of clinical deterioration using machine-learning early warning scores may improve outcomes. However, most implemented scores were developed using logistic regression, only underwent retrospective validation, and were not tested in important subgroups. OBJECTIVE: The objective of our multicenter retrospective and prospective observational study was to develop and prospectively validate a gradient-boosted machine model (eCARTv5) for identifying clinical deterioration on the wards. DERIVATION COHORT: All adult patients admitted to the inpatient medical-surgical wards at seven hospitals in three health systems for model development (2006–2022). VALIDATION COHORT: All adult patients admitted to the inpatient medical-surgical wards and at 21 hospitals from three health systems for retrospective (2009–2023) and prospective (2023–2024) external validation. PREDICTION MODEL: Predictor variables (demographics, vital signs, documentation, and laboratory values) were used in a gradient-boosted trees algorithm to predict ICU transfer or death in the next 24 hours. The developed model (eCARTv5) was compared with the Modified Early Warning Score (MEWS), the National Early Warning Score (NEWS), and eCARTv2 using the area under the receiver operating characteristic curve (AUROC). RESULTS: The development cohort included 901,491 admissions, the retrospective validation cohort included 1,769,461 admissions, and the prospective validation cohort included 205,946 admissions. In retrospective validation, eCARTv5 had the highest AUROC (0.834; 95% CI, 0.834–0.835), followed by eCARTv2 (0.775 [95% CI, 0.775–0.776]), NEWS (0.766 [95% CI, 0.766–0.767]), and MEWS (0.704 [95% CI, 0.703–0.704]). eCARTv5’s performance remained high (AUROC ≥0.80) across a range of patient demographics, clinical conditions, and during prospective validation. CONCLUSION: We developed eCARTv5, which performed better than eCARTv2, NEWS, and MEWS retrospectively, prospectively, and across a range of subgroups. These results served as the foundation for Food and Drug Administration clearance for its use in identifying deterioration in hospitalized ward patients.
- 26 March 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (4) , e1232
Open AccessMulticenter Development and Prospective Validation of eCARTv5: A Gradient-Boosted Machine-Learning Early Warning Score
BACKGROUND: Early detection of clinical deterioration using machine-learning early warning scores may improve outcomes. However, most implemented scores were developed using logistic regression, only underwent retrospective validation, and were not tested in important subgroups. OBJECTIVE: The objective of our multicenter retrospective and prospective observational study was to develop and prospectively validate a gradient-boosted machine model (eCARTv5) for identifying clinical deterioration on the wards. DERIVATION COHORT: All adult patients admitted to the inpatient medical-surgical wards at seven hospitals in three health systems for model development (2006–2022). VALIDATION COHORT: All adult patients admitted to the inpatient medical-surgical wards and at 21 hospitals from three health systems for retrospective (2009–2023) and prospective (2023–2024) external validation. PREDICTION MODEL: Predictor variables (demographics, vital signs, documentation, and laboratory values) were used in a gradient-boosted trees algorithm to predict ICU transfer or death in the next 24 hours. The developed model (eCARTv5) was compared with the Modified Early Warning Score (MEWS), the National Early Warning Score (NEWS), and eCARTv2 using the area under the receiver operating characteristic curve (AUROC). RESULTS: The development cohort included 901,491 admissions, the retrospective validation cohort included 1,769,461 admissions, and the prospective validation cohort included 205,946 admissions. In retrospective validation, eCARTv5 had the highest AUROC (0.834; 95% CI, 0.834–0.835), followed by eCARTv2 (0.775 [95% CI, 0.775–0.776]), NEWS (0.766 [95% CI, 0.766–0.767]), and MEWS (0.704 [95% CI, 0.703–0.704]). eCARTv5’s performance remained high (AUROC ≥0.80) across a range of patient demographics, clinical conditions, and during prospective validation. CONCLUSION: We developed eCARTv5, which performed better than eCARTv2, NEWS, and MEWS retrospectively, prospectively, and across a range of subgroups. These results served as the foundation for Food and Drug Administration clearance for its use in identifying deterioration in hospitalized ward patients.
- 19 July 2024
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 6 (7) , e1116
Development and Validation of a Machine Learning COVID-19 Veteran (COVet) Deterioration Risk Score
BACKGROUND AND OBJECTIVE: To develop the COVid Veteran (COVet) score for clinical deterioration in Veterans hospitalized with COVID-19 and further validate this model in both Veteran and non-Veteran samples. No such score has been derived and validated while incorporating a Veteran sample. DERIVATION COHORT: Adults (age ≥ 18 yr) hospitalized outside the ICU with a diagnosis of COVID-19 for model development to the Veterans Health Administration (VHA) (n = 80 hospitals). VALIDATION COHORT: External validation occurred in a VHA cohort of 34 hospitals, as well as six non-Veteran health systems for further external validation (n = 21 hospitals) between 2020 and 2023. PREDICTION MODEL: eXtreme Gradient Boosting machine learning methods were used, and performance was assessed using the area under the receiver operating characteristic curve and compared with the National Early Warning Score (NEWS). The primary outcome was transfer to the ICU or death within 24 hours of each new variable observation. Model predictor variables included demographics, vital signs, structured flowsheet data, and laboratory values. RESULTS: A total of 96,908 admissions occurred during the study period, of which 59,897 were in the Veteran sample and 37,011 were in the non-Veteran sample. During external validation in the Veteran sample, the model demonstrated excellent discrimination, with an area under the receiver operating characteristic curve of 0.88. This was significantly higher than NEWS (0.79; p < 0.01). In the non-Veteran sample, the model also demonstrated excellent discrimination (0.86 vs. 0.79 for NEWS; p < 0.01). The top three variables of importance were eosinophil percentage, mean oxygen saturation in the prior 24-hour period, and worst mental status in the prior 24-hour period. CONCLUSIONS: We used machine learning methods to develop and validate a highly accurate early warning score in both Veterans and non-Veterans hospitalized with COVID-19. The model could lead to earlier identification and therapy, which may improve outcomes.
- 19 July 2024
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 6 (7) , e1116
Development and Validation of a Machine Learning COVID-19 Veteran (COVet) Deterioration Risk Score
BACKGROUND AND OBJECTIVE: To develop the COVid Veteran (COVet) score for clinical deterioration in Veterans hospitalized with COVID-19 and further validate this model in both Veteran and non-Veteran samples. No such score has been derived and validated while incorporating a Veteran sample. DERIVATION COHORT: Adults (age ≥ 18 yr) hospitalized outside the ICU with a diagnosis of COVID-19 for model development to the Veterans Health Administration (VHA) (n = 80 hospitals). VALIDATION COHORT: External validation occurred in a VHA cohort of 34 hospitals, as well as six non-Veteran health systems for further external validation (n = 21 hospitals) between 2020 and 2023. PREDICTION MODEL: eXtreme Gradient Boosting machine learning methods were used, and performance was assessed using the area under the receiver operating characteristic curve and compared with the National Early Warning Score (NEWS). The primary outcome was transfer to the ICU or death within 24 hours of each new variable observation. Model predictor variables included demographics, vital signs, structured flowsheet data, and laboratory values. RESULTS: A total of 96,908 admissions occurred during the study period, of which 59,897 were in the Veteran sample and 37,011 were in the non-Veteran sample. During external validation in the Veteran sample, the model demonstrated excellent discrimination, with an area under the receiver operating characteristic curve of 0.88. This was significantly higher than NEWS (0.79; p < 0.01). In the non-Veteran sample, the model also demonstrated excellent discrimination (0.86 vs. 0.79 for NEWS; p < 0.01). The top three variables of importance were eosinophil percentage, mean oxygen saturation in the prior 24-hour period, and worst mental status in the prior 24-hour period. CONCLUSIONS: We used machine learning methods to develop and validate a highly accurate early warning score in both Veterans and non-Veterans hospitalized with COVID-19. The model could lead to earlier identification and therapy, which may improve outcomes.